EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Plasma metabolomic profiles associated with breastfeeding history and subsequent ovarian cancer risk

Jennifer M Mongiovi, Nicole Prince, Julian Avila Pacheco, Nan Lin, Mary K Townsend, Britton Trabert, Nicolas Wentzensen, Jessica A Lasky-Su, A Heather Eliassen, Clary B Clish, Shelley S Tworoger, Oana A Zeleznik, Naoko Sasamoto

JNCI Cancer Spectrum · 2026-11-02 · 10 (6)

DOI: 10.1093/jncics/pkag108 ↗
AbstractBibliografische Angaben

Abstract

Abstract Background Breastfeeding reduces ovarian cancer risk, but the underlying biological mechanisms remain unclear. Methods We examined the association between a previously reported metabolite-based breastfeeding score with incident epithelial ovarian cancer risk in case-control studies nested within the Nurses’ Health Studies (NHS/NHSII, n = 436) and Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO, n = 300) using conditional logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for each study and conducted a meta-analysis. We investigated 606 individual breastfeeding-metabolite associations among 9904 midlife parous women in NHS/NHSII and 663 1-year postpartum women in the Vitamin D Antenatal Asthma Reduction Trial (VDAART). Metabolites associated with breastfeeding at P ≤ .05 after multiple testing correction for number of effective tests (NEF) were then assessed for their associations with ovarian cancer. Metabolite set enrichment analysis using Normalized Enrichment Score (NES)-identified metabolite classes associated with breastfeeding using false discovery rate (FDR) for multiple testing correction. Results The highest quartile of metabolite-based breastfeeding score was inversely associated with ovarian cancer risk (meta-analyzed odds ratio [OR] = 0.62, 95% CI = 0.39 to 0.99). Of the 14 individual metabolites associated with breastfeeding in NHS/NHSII and also measured in VDAART, similar direction of associations was observed for 11 metabolites. Phosphatidylcholines (PCs; NES = 1.94; FDR = 0.004) and phosphatidylethanolamines (PEs; NES = 1.82; FDR = 0.01) were positively enriched with increased breastfeeding duration. Ten metabolites including PCs and PEs were positively associated with breastfeeding and inversely associated with ovarian cancer. Conclusion Our results suggest alterations of systemic metabolism, particularly among PC and PE pathways, provide insight into biological pathways underlying the inverse breastfeeding-ovarian cancer association.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →